Category Archives: Cardiac Regeneration

The letter follows. Dear AgeX Stockholders, In this, our first year as a public company, we have built a foundation for a revolutionary company in the fields of cell therapy and tissue regeneration. To date, conventional pharmaceutical approaches to the chronic degenerative conditions associated with aging have provided little benefit, often only offering relief from the symptoms of disease, rather than targeting underlying disease processes. Continue reading →

Recently, a new study that appears in the journal Nature, focuses on stem cell therapy and shows unexpected ways in which it may be helpful in recovering the health of the heart. Stem cell therapy has become popular in the past few years due to its benefits for a big number of health conditions Continue reading →

OBJECTIVES: Stem cell therapy is a promising approach in the treatment of acutemyocardial infarction(AMI). Mesenchymal stem cells (MSC) from bone marrow (BM-MSC) and adipose tissue (AT-MSC) are attractive and feasible for preclinical and clinical trials. Continue reading →

Investment Thesis A promising set of initial trial data and a rich portfolio of drugs has not stoked investor interest yet for Moderna, Inc. (MRNA) Continue reading →

SUWANEE, Ga., Nov. 15, 2019 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc.(OTCQB: SNWV)reported financial results for the three and nine months ended September 30, 2019 with the SEC on Thursday, November 14, 2019 Continue reading →

Heart failure (HF) is the most frequent cardiovascular diagnosis and exacts significant health and financial costs around the globe. It is estimated that at least 26 million people worldwide are living with HF, including nearly 6 million in the United States.1, 2 One in nine U.S. deaths in 2009 included heart failure as a contributing cause and about 50 percent of people in the U.S. Continue reading →

DUBLIN--(BUSINESS WIRE)--The "Global, U.S. & Europe Regenerative Medicines Market Demand Analysis & Opportunity Evaluation, 2019-2027" report has been added to ResearchAndMarkets.com's offering Continue reading →

It took years for Emilio Alarcon and his University of Ottawa Heart Institute research team to fully believe what they were seeing that a gel they had developed containing human collagen was repairing damaged hearts in mice. They repeated their research study several times, coming up with randomized, blinded results, just to make sure the findings were correct. Continue reading →

Regenerative Medicine Market: Snapshot Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering. This type of medicine involves replacing and regenerating human cells, organs, and tissues with the help of specific processes. Continue reading →

LOS ANGELES, Oct. Continue reading →